Latest
Press Release
Mymetics Corporation Acquires Preventive Malaria Vaccine From Pevion Biotech AG (Switzerland).
Successful Phase I and II Clinical Trials In Switzerland and the UK.
Results praised by an eminent member of the Pasteur Institute and of the malaria board of the Bill and Melinda Gates Foundation.
Nyon, Switzerland (May 19, 2008)
Mymetics Corporation (OTCBB: MYMX), a vaccine development company, made the acquisition of a preventive malaria vaccine from Pevion Biotech AG, a privately-held biotech company based in Switzerland. [more] |
|